PMS2 and Lynch syndrome: In another study, the risk of developing breast cancer in individuals with Lynch syndrome with the MLH1, MSH2, MSH6, and PMS2 pathogenic variants increased to 12.3%, 14.6%, 13.7%, and 15.2%, respectively, by age 75 [20].